These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31409898)

  • 1. LSD1 suppresses invasion, migration and metastasis of luminal breast cancer cells via activation of GATA3 and repression of TRIM37 expression.
    Hu X; Xiang D; Xie Y; Tao L; Zhang Y; Jin Y; Pinello L; Wan Y; Yuan GC; Li Z
    Oncogene; 2019 Oct; 38(44):7017-7034. PubMed ID: 31409898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The R251Q mutation of LSD1 promotes invasion and migration of luminal breast cancer cells.
    Zhang Y; Wu T; Wang Y; Zhao X; Zhao B; Zhao X; Zhang Q; Jin Y; Li Z; Hu X
    Int J Biol Macromol; 2020 Dec; 164():4000-4009. PubMed ID: 32882276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E239K mutation abolishes the suppressive effects of lysine-specific demethylase 1 on migration and invasion of MCF7 cells.
    Zhang Y; Wu T; Zhao B; Liu Z; Qian R; Zhang J; Shi Y; Wan Y; Li Z; Hu X
    Cancer Sci; 2022 Feb; 113(2):489-499. PubMed ID: 34839571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer.
    Przanowski P; Lou S; Tihagam RD; Mondal T; Conlan C; Shivange G; Saltani I; Singh C; Xing K; Morris BB; Mayo MW; Teixeira L; Lehmann-Che J; Tushir-Singh J; Bhatnagar S
    Cancer Res; 2020 Nov; 80(21):4791-4804. PubMed ID: 32855208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM37 is a new histone H2A ubiquitin ligase and breast cancer oncoprotein.
    Bhatnagar S; Gazin C; Chamberlain L; Ou J; Zhu X; Tushir JS; Virbasius CM; Lin L; Zhu LJ; Wajapeyee N; Green MR
    Nature; 2014 Dec; 516(7529):116-20. PubMed ID: 25470042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM37 Promotes Pancreatic Cancer Progression through Modulation of Cell Growth, Migration, Invasion, and Tumor Immune Microenvironment.
    Do TT; Yeh CC; Wu GW; Hsu CC; Chang HC; Chen HC
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM37 controls cancer-specific vulnerability to PLK4 inhibition.
    Meitinger F; Ohta M; Lee KY; Watanabe S; Davis RL; Anzola JV; Kabeche R; Jenkins DA; Shiau AK; Desai A; Oegema K
    Nature; 2020 Sep; 585(7825):440-446. PubMed ID: 32908304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology.
    Lim S; Janzer A; Becker A; Zimmer A; Schüle R; Buettner R; Kirfel J
    Carcinogenesis; 2010 Mar; 31(3):512-20. PubMed ID: 20042638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM37 orchestrates renal cell carcinoma progression via histone H2A ubiquitination-dependent manner.
    Miao C; Liang C; Li P; Liu B; Qin C; Yuan H; Liu Y; Zhu J; Cui Y; Xu A; Wang S; Su S; Li J; Shao P; Wang Z
    J Exp Clin Cancer Res; 2021 Jun; 40(1):195. PubMed ID: 34130705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM37 Augments AP-2γ Transcriptional Activity and Cellular Localization via K63-linked Ubiquitination to Drive Breast Cancer Progression.
    Cui G; Gao Z; Chang S; Narwade N; Chen Y; Poudel B; Lei KMK; Zhang W; Li G; Poon TCW; Cheung E
    Int J Biol Sci; 2022; 18(11):4316-4328. PubMed ID: 35864973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression.
    Cao C; Vasilatos SN; Bhargava R; Fine JL; Oesterreich S; Davidson NE; Huang Y
    Oncogene; 2017 Jan; 36(1):133-145. PubMed ID: 27212032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer.
    Hosseinzadeh L; Kikhtyak Z; Laven-Law G; Pederson SM; Puiu CG; D'Santos CS; Lim E; Carroll JS; Tilley WD; Dwyer AR; Hickey TE
    Genome Biol; 2024 Feb; 25(1):44. PubMed ID: 38317241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of lysine-specific demethylase LSD1 induces senescence in Glioblastoma cells through a HIF-1α-dependent pathway.
    Saccà CD; Gorini F; Ambrosio S; Amente S; Faicchia D; Matarese G; Lania L; Majello B
    Biochim Biophys Acta Gene Regul Mech; 2019 May; 1862(5):535-546. PubMed ID: 30951900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition.
    Lin T; Ponn A; Hu X; Law BK; Lu J
    Oncogene; 2010 Sep; 29(35):4896-904. PubMed ID: 20562920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GATA3 recruits UTX for gene transcriptional activation to suppress metastasis of breast cancer.
    Yu W; Huang W; Yang Y; Qiu R; Zeng Y; Hou Y; Sun G; Shi H; Leng S; Feng D; Chen Y; Wang S; Teng X; Yu H; Wang Y
    Cell Death Dis; 2019 Nov; 10(11):832. PubMed ID: 31685800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The histone demethylase LSD1/KDM1A promotes the DNA damage response.
    Mosammaparast N; Kim H; Laurent B; Zhao Y; Lim HJ; Majid MC; Dango S; Luo Y; Hempel K; Sowa ME; Gygi SP; Steen H; Harper JW; Yankner B; Shi Y
    J Cell Biol; 2013 Nov; 203(3):457-70. PubMed ID: 24217620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of downstream metastasis-associated target genes regulated by LSD1 in colon cancer cells.
    Chen J; Ding J; Wang Z; Zhu J; Wang X; Du J
    Oncotarget; 2017 Mar; 8(12):19609-19630. PubMed ID: 28121627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C1orf106, an innate immunity activator, is amplified in breast cancer and is required for basal-like/luminal progenitor fate decision.
    Ma J; Liu C; Yang D; Song J; Zhang J; Wang T; Wang M; Xu W; Li X; Ding S; Zhan J; Zhang H
    Sci China Life Sci; 2019 Sep; 62(9):1229-1242. PubMed ID: 31376015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LSD1-mediated epigenetic modification contributes to proliferation and metastasis of colon cancer.
    Ding J; Zhang ZM; Xia Y; Liao GQ; Pan Y; Liu S; Zhang Y; Yan ZS
    Br J Cancer; 2013 Aug; 109(4):994-1003. PubMed ID: 23900215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FBXO24 Suppresses Breast Cancer Tumorigenesis by Targeting LSD1 for Ubiquitination.
    Dong B; Song X; Wang X; Dai T; Wang J; Yu Z; Deng J; Evers BM; Wu Y
    Mol Cancer Res; 2023 Dec; 21(12):1303-1316. PubMed ID: 37540490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.